Cargando…

Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months

Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is, keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation of virus particles would address the problem. Here we propose and characterize additives that, already at very low conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelliccia, Maria, Andreozzi, Patrizia, Paulose, Jayson, D'Alicarnasso, Marco, Cagno, Valeria, Donalisio, Manuela, Civra, Andrea, Broeckel, Rebecca M., Haese, Nicole, Jacob Silva, Paulo, Carney, Randy P., Marjomäki, Varpu, Streblow, Daniel N., Lembo, David, Stellacci, Francesco, Vitelli, Vincenzo, Krol, Silke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141364/
https://www.ncbi.nlm.nih.gov/pubmed/27901019
http://dx.doi.org/10.1038/ncomms13520
_version_ 1782472598633840640
author Pelliccia, Maria
Andreozzi, Patrizia
Paulose, Jayson
D'Alicarnasso, Marco
Cagno, Valeria
Donalisio, Manuela
Civra, Andrea
Broeckel, Rebecca M.
Haese, Nicole
Jacob Silva, Paulo
Carney, Randy P.
Marjomäki, Varpu
Streblow, Daniel N.
Lembo, David
Stellacci, Francesco
Vitelli, Vincenzo
Krol, Silke
author_facet Pelliccia, Maria
Andreozzi, Patrizia
Paulose, Jayson
D'Alicarnasso, Marco
Cagno, Valeria
Donalisio, Manuela
Civra, Andrea
Broeckel, Rebecca M.
Haese, Nicole
Jacob Silva, Paulo
Carney, Randy P.
Marjomäki, Varpu
Streblow, Daniel N.
Lembo, David
Stellacci, Francesco
Vitelli, Vincenzo
Krol, Silke
author_sort Pelliccia, Maria
collection PubMed
description Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is, keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation of virus particles would address the problem. Here we propose and characterize additives that, already at very low concentrations, improve the storage time of adenovirus type 5. Anionic gold nanoparticles (10(−8)–10(−6) M) or polyethylene glycol (PEG, molecular weight ∼8,000 Da, 10(−7)–10(−4) M) increase the half-life of a green fluorescent protein expressing adenovirus from ∼48 h to 21 days at 37 °C (from 7 to >30 days at room temperature). They replicate the known stabilizing effect of sucrose, but at several orders of magnitude lower concentrations. PEG and sucrose maintained immunogenicity in vivo for viruses stored for 10 days at 37 °C. To achieve rational design of viral-vaccine stabilizers, our approach is aided by simplified quantitative models based on a single rate-limiting step.
format Online
Article
Text
id pubmed-5141364
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51413642016-12-13 Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months Pelliccia, Maria Andreozzi, Patrizia Paulose, Jayson D'Alicarnasso, Marco Cagno, Valeria Donalisio, Manuela Civra, Andrea Broeckel, Rebecca M. Haese, Nicole Jacob Silva, Paulo Carney, Randy P. Marjomäki, Varpu Streblow, Daniel N. Lembo, David Stellacci, Francesco Vitelli, Vincenzo Krol, Silke Nat Commun Article Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is, keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation of virus particles would address the problem. Here we propose and characterize additives that, already at very low concentrations, improve the storage time of adenovirus type 5. Anionic gold nanoparticles (10(−8)–10(−6) M) or polyethylene glycol (PEG, molecular weight ∼8,000 Da, 10(−7)–10(−4) M) increase the half-life of a green fluorescent protein expressing adenovirus from ∼48 h to 21 days at 37 °C (from 7 to >30 days at room temperature). They replicate the known stabilizing effect of sucrose, but at several orders of magnitude lower concentrations. PEG and sucrose maintained immunogenicity in vivo for viruses stored for 10 days at 37 °C. To achieve rational design of viral-vaccine stabilizers, our approach is aided by simplified quantitative models based on a single rate-limiting step. Nature Publishing Group 2016-11-30 /pmc/articles/PMC5141364/ /pubmed/27901019 http://dx.doi.org/10.1038/ncomms13520 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Pelliccia, Maria
Andreozzi, Patrizia
Paulose, Jayson
D'Alicarnasso, Marco
Cagno, Valeria
Donalisio, Manuela
Civra, Andrea
Broeckel, Rebecca M.
Haese, Nicole
Jacob Silva, Paulo
Carney, Randy P.
Marjomäki, Varpu
Streblow, Daniel N.
Lembo, David
Stellacci, Francesco
Vitelli, Vincenzo
Krol, Silke
Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
title Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
title_full Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
title_fullStr Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
title_full_unstemmed Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
title_short Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
title_sort additives for vaccine storage to improve thermal stability of adenoviruses from hours to months
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141364/
https://www.ncbi.nlm.nih.gov/pubmed/27901019
http://dx.doi.org/10.1038/ncomms13520
work_keys_str_mv AT pellicciamaria additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT andreozzipatrizia additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT paulosejayson additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT dalicarnassomarco additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT cagnovaleria additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT donalisiomanuela additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT civraandrea additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT broeckelrebeccam additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT haesenicole additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT jacobsilvapaulo additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT carneyrandyp additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT marjomakivarpu additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT streblowdanieln additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT lembodavid additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT stellaccifrancesco additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT vitellivincenzo additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths
AT krolsilke additivesforvaccinestoragetoimprovethermalstabilityofadenovirusesfromhourstomonths